Resistance to immunotherapy is associated with high parenchymal PD1+CD8+/CD8+ T cells (PD1tR) driven by tumour CD155A. Lepletier de Oliveira, Mark J. Smyth, Jake S. O’Donnell et al.|Annals of Oncology|2019Cited by 1